By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Meridian Bioscience, Inc. 


3471 River Hills Drive
Cincinnati  Ohio  45244  U.S.A.
Phone: 513-271-3700 Fax: 513-271-3762


SEARCH JOBS
Meridian Bioscience is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Our products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori., foodborne diseases. and respiratory infections.

For more than 30 years, Meridian Bioscience, Inc., has established a proven track record of profitable growth and product launches designed to enhance patient well being while reducing the total outcome costs of healthcare. Meridian diagnostic products are used outside of the human body and require little or no special equipment.

We maintain market leadership by responding to emerging diseases and changing medical needs. Since 1991, Meridian has developed and introduced more than 56 innovative products. Meridian also grows through acquisition, licensing, or supply agreements that have added almost 100 new products to our catalog.

Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis. We actively market our products to hospitals, reference laboratories, research centers, physician offices and diagnostics manufacturers in more than 60 countries around the world.

Our shares are traded on the NASDAQ National Market, symbol VIVO.


Key Statistics


Email:
Ownership: Public

Web Site: Meridian Bioscience, Inc.
Employees:
Symbol: VIVO
 









Company News
Meridian Bioscience, Inc. (VIVO) And The University Of Tennessee Research Foundation Enter Into A License Agreement For Electrokinetic Sensor Technology 8/6/2014 10:38:55 AM
Meridian Bioscience, Inc. (VIVO) Reports Third Quarter And Nine Months Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2014 Guidance 7/24/2014 11:51:29 AM
Meridian Bioscience, Inc. (VIVO) Receives Canadian Licenses For IllumigeneĀ® Mycoplasma And IllumigeneĀ® Pertussis 5/28/2014 10:15:20 AM
Meridian Bioscience, Inc. (VIVO) Reports Second Quarter 2014 Operating Results And Revises Fiscal 2014 Guidance 4/24/2014 7:26:27 AM
Meridian Bioscience, Inc. (VIVO) Wins FDA Approval For Rapid 60-Minute Pertussis Molecular Assay Test 3/28/2014 6:45:48 AM
Meridian Bioscience, Inc. (VIVO) Reports First Quarter 2014 Operating Results, Declares Increased Regular Cash Dividend, And Reaffirms Fiscal 2014 Guidance 1/22/2014 6:33:43 AM
Meridian Bioscience, Inc. (VIVO) Granted Special 510(k) Clearance For TRU FLU® To Add Avian H7N9 Influenza A Virus Analytical Sensitivity Claim 1/12/2014 8:46:47 PM
Meridian Bioscience, Inc. (VIVO) Release: PCR From Whole Blood, Simplified 11/14/2013 9:24:41 AM
Meridian Bioscience, Inc. (VIVO) Reports Record Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, Announces Increased Regular Cash Dividend Rate for Fiscal 2014, and Reaffirms Fiscal 2014 Guidance 11/7/2013 8:27:08 AM
Meridian Bioscience, Inc. (VIVO) Provides Sales and Earnings Guidance for Fiscal 2014 and Reaffirms Fiscal 2013 Guidance 9/9/2013 8:39:15 AM
12345678910...
//-->